Patient/tumor characteristic and their associations with the expression of the 15-gene signature in the in-house stage II colorectal cancer validation cohort
Funding
Deutschen Konsortium für Translationale Krebsforschung (DKTK)
History
ARTICLE ABSTRACT
We identified and validated a 15-gene expression signature for robust prognostication and stratification of patients with stage II colorectal cancer, with superior performance when compared with currently used biomarkers. Therefore, the 15-gene expression signature has the potential to improve the prognostication and treatment decisions for patients with stage II colorectal cancer.